To be effective in treating respiratory illnesses, liquid drugs must be utilized in an aerosol with an effective and defined drop size distribution for inhaled medications. To meet these intense ...

LANGHORNE, Pa., December 02, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. If you’re dealing with a respiratory illness, it can be ...

- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.

The MiniElite compressor nebulizer system is compact, lightweight, and designed for patient convenience. It can be powered by three versatile power sources- 110V AC, 12V DC (car) and an optional ...

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial. Sunovion announced the launch of Lonhala Magnair (glycopyrrolate) inhalation solution for the long-term, maintenance ...

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world ...

U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa - First ...

An Islip doctor who helped author a state law that led to greater availability of nebulizers to treat asthma in schools said he is concerned that new federal guidelines, favoring specially adapted ...

Autoimmune PAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Surfactant consists of proteins and lipids and is an important physiological ...